Literature DB >> 19215723

A fatal case of Lassa fever in London, January 2009.

A Kitching1, S Addiman, S Cathcart, L Bischop, D Krahé, M Nicholas, J Coakley, G Lloyd, T Brooks, D Morgan, D Turbitt.   

Abstract

In January 2009, the eleventh [corrected] case of Lassa fever imported to the United Kingdom was diagnosed in London. Risk assessment of 328 healthcare contacts with potential direct exposure to Lassa virus - through contact with the case or exposure to bodily fluids - was undertaken. No contacts were assessed to be at high risk of infection and no secondary clinical cases identified.

Entities:  

Mesh：

Year:  2009        PMID： 19215723

Source DB:  PubMed          Journal:  Euro Surveill        ISSN： 1025-496X


  40 in total

1.  Conserved residues in Lassa fever virus Z protein modulate viral infectivity at the level of the ribonucleoprotein.

Authors:  Althea A Capul; Juan Carlos de la Torre; Michael J Buchmeier
Journal:  J Virol       Date:  2011-01-12       Impact factor: 5.103

2.  Arenavirus Genome Rearrangement for the Development of Live Attenuated Vaccines.

Authors:  Benson Yee Hin Cheng; Emilio Ortiz-Riaño; Juan Carlos de la Torre; Luis Martínez-Sobrido
Journal:  J Virol       Date:  2015-05-13       Impact factor: 5.103

3.  Potential for Seasonal Lassa Fever Case Exportation from Nigeria.

Authors:  Ashleigh R Tuite; Alexander G Watts; Moritz U G Kraemer; Kamran Khan; Isaac I Bogoch
Journal:  Am J Trop Med Hyg       Date:  2019-03       Impact factor: 2.345

4.  Early-onset sensorineural hearing loss in Lassa fever.

Authors:  T S Ibekwe; P O Okokhere; D Asogun; F F Blackie; M M Nwegbu; K W Wahab; S A Omilabu; G O Akpede
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-09-01       Impact factor: 2.503

5.  Evolution of recombinant lymphocytic choriomeningitis virus/Lassa virus in vivo highlights the importance of the GPC cytosolic tail in viral fitness.

Authors:  Rami Sommerstein; Joel Ramos da Palma; Stephan Olschläger; Andreas Bergthaler; Leticia Barba; Boris P-L Lee; Antonella Pasquato; Lukas Flatz
Journal:  J Virol       Date:  2014-05-14       Impact factor: 5.103

6.  Expression and X-Ray Structural Determination of the Nucleoprotein of Lassa Fever Virus.

Authors:  Xiaoxuan Qi; Wenjian Wang; Haohao Dong; Yuying Liang; Changjiang Dong; Hinh Ly
Journal:  Methods Mol Biol       Date:  2018

7.  Constraints in the diagnosis and treatment of Lassa Fever and the effect on mortality in hospitalized children and women with obstetric conditions in a rural district hospital in Sierra Leone.

Authors:  A Dahmane; J van Griensven; M Van Herp; R Van den Bergh; Y Nzomukunda; J Prior; P Alders; A Jambai; R Zachariah
Journal:  Trans R Soc Trop Med Hyg       Date:  2014-03       Impact factor: 2.184

8.  Diagnostic issues and capabilities in 48 isolation facilities in 16 European countries: data from EuroNHID surveys.

Authors:  Simon-Djamel Thiberville; Stefan Schilling; Giuseppina De Iaco; Francesco Maria Fusco; Gail Thomson; Helen C Maltezou; Rene Gottschalk; Reinhard H Brodt; Barbara Bannister; Vincenzo Puro; Giuseppe Ippolito; Philippe Brouqui
Journal:  BMC Res Notes       Date:  2012-09-25

Review 9.  Advanced vaccine candidates for Lassa fever.

Authors:  Igor S Lukashevich
Journal:  Viruses       Date:  2012-10-29       Impact factor: 5.048

Review 10.  Multifunctional nature of the arenavirus RING finger protein Z.

Authors:  Sarah Katharina Fehling; Frank Lennartz; Thomas Strecker
Journal:  Viruses       Date:  2012-11-09       Impact factor: 5.048
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.